Speaking at the GITEX Technology Expo at the Dubai World Trade Center from 6 to 10 October 2019, Farid Faraidouni said that the digital revolution has contributed to the emergence of many technologies that can be used to improve all aspects of our life and activities, and We believe the future More in store for these techniques.
“In particular, AI technology has unlimited potential that can be exploited and exploited to improve our communities, improve the quality and efficiency of operations in all sectors and find solutions to the challenges that may arise in the future. Have positive effects on the sector by removing the current obstacles affecting the efficiency of the diagnostic procedures followed and on improving patient safety.
Recent studies show that 17.3% of the population of the United Arab Emirates has type 2 diabetes and this rate may increase. The diabetic retinopathy screening platform based on artificial intelligence, presented at GITEX Technology 2019 from 6 to 10 October 2019, in collaboration with doctors and general practitioners, will help to make rapid diagnostic and decision-making references for diabetic patients. Good time for ophthalmologists.
The exhibition highlighted the experience of the new solution for screening diabetic retinopathy to find out for yourself how easy it is to upload images and detect eye anomalies during a live presentation on the platform.
Over time, diabetes damages the small blood vessels in the eyes, causing diabetic retinopathy, which increases the risk of blindness, which is worrying that most diabetics do not notice the seriousness of this condition until the later stages.
The new solution provides retinal images of both eyes, acquired using an advanced fundus scanning camera, which is then loaded and processed into a secure cloud-based platform, after which the artificial intelligence system automatically analyzes the images and send the result in less than a minute.
The solution therefore provides a report containing the results of the examination on diabetic retinopathy with a clear index of image quality, together with the measurement of the severity of diabetic retinopathy and clear images of the entire retina.